Reuters logo
BRIEF-Amicus Therapeutics Q3 loss per share $0.69
November 8, 2017 / 2:29 PM / in 12 days

BRIEF-Amicus Therapeutics Q3 loss per share $0.69

Nov 8 (Reuters) - Amicus Therapeutics Inc:

* Amicus therapeutics announces third quarter 2017 financial results and corporate updates

* Q3 loss per share $0.69

* Q3 revenue $10.9 million versus I/B/E/S view $9.5 million

* Q3 adjusted loss per share $0.41 excluding items

* Q3 earnings per share view $-0.31 -- Thomson Reuters I/B/E/S

* Amicus Therapeutics Inc - ‍reiterated full-year 2017 financial guidance​

* Amicus Therapeutics Inc - ‍current cash position anticipated to fund ongoing operations into at least H2 2019​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below